BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 30326912)

  • 1. Analysis of definitive chemo-radiotherapy for esophageal cancer with supra-clavicular node metastasis based on CT in a single institutional retrospective study: a propensity score matching analysis.
    Xu HY; Wu SX; Luo HS; Chen CY; Lin LX; Huang HC
    Radiat Oncol; 2018 Oct; 13(1):200. PubMed ID: 30326912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supraclavicular node disease is not an independent prognostic factor for survival of esophageal cancer patients treated with definitive chemoradiation.
    Jeene PM; Versteijne E; van Berge Henegouwen MI; Bergmann JJ; Geijsen ED; van Laarhoven HW; Hulshof MC
    Acta Oncol; 2017 Jan; 56(1):33-38. PubMed ID: 27842455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of Cervical Cancer Patients Presenting with Occult Supraclavicular Metastases Detected by FDG-Positron Emission Tomography/CT: Impact of Disease Extent and Treatment.
    Ioffe YJ; Massad LS; Powell MA; Hagemann AR; Mutch DG; Thaker PH; Schwarz JK; Grigsby PW
    Gynecol Obstet Invest; 2018; 83(1):83-89. PubMed ID: 28399524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical impact of supraclavicular lymph node metastasis in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy.
    Chen YH; Lu HI; Lo CM; Wang YM; Chou SY; Huang CH; Shih LH; Chen SW; Li SH
    PLoS One; 2018; 13(6):e0198800. PubMed ID: 29889869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical lymph node dissection for clinically submucosal carcinoma of the thoracic esophagus.
    Kosugi S; Kawaguchi Y; Kanda T; Ishikawa T; Sakamoto K; Akaike H; Fujii H; Wakai T
    Ann Surg Oncol; 2013 Nov; 20(12):4016-21. PubMed ID: 23892526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Outcomes of Resectable Esophageal Cancer with Supraclavicular Lymph Node Metastases Treated with Curative Intent.
    Honma Y; Hokamura N; Nagashima K; Sudo K; Shoji H; Iwasa S; Takashima A; Kato K; Hamaguchi T; Boku N; Umezawa R; Ito Y; Itami J; Koyanagi K; Igaki H; Tachimori Y
    Anticancer Res; 2017 Jul; 37(7):3741-3749. PubMed ID: 28668869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nodal FDG-PET/CT uptake influences outcome and relapse location among esophageal cancer patients submitted to chemotherapy or radiochemotherapy.
    Jimenez-Jimenez E; Mateos P; Ortiz I; Aymar N; Roncero R; Gimenez M; Pardo J; Sabater S
    Clin Transl Oncol; 2019 Sep; 21(9):1159-1167. PubMed ID: 30661172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Significance of Standardized Uptake Value of Lymph Nodes on Survival for Stage III Non-small Cell Lung Cancer Treated With Definitive Concurrent Chemoradiotherapy.
    Lee VH; Chan WW; Lee EY; Choy TS; Ho PP; Leung DK; Lam KO; Kwong DL; Leung TW; Khong PL
    Am J Clin Oncol; 2016 Aug; 39(4):355-62. PubMed ID: 24710123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of nodal maximum standardized uptake value of pretreatment [18F]fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancer.
    Yap WK; Chang YC; Tseng CK; Hsieh CH; Chao YK; Su PJ; Hou MM; Yang CK; Pai PC; Lin CR; Hsieh CE; Wu YY; Hung TM
    Dis Esophagus; 2017 Aug; 30(8):1-10. PubMed ID: 28575243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis on CT in diagnosis of lymph node metastasis of thoracic esophageal cancer with minimum diameter greater than 1 cm].
    Wu HR; Liu CQ; Guo MF; Xu MQ; Mei XY
    Zhonghua Wai Ke Za Zhi; 2019 Aug; 57(8):601-606. PubMed ID: 31422630
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of a predictive factor for distant metastasis in esophageal squamous cell carcinoma after definitive chemoradiotherapy.
    Sakanaka K; Ishida Y; Itasaka S; Ezoe Y; Aoyama I; Miyamoto S; Horimatsu T; Muto M; Hiraoka M
    Int J Clin Oncol; 2016 Oct; 21(5):899-908. PubMed ID: 26936851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship of gross tumor volume with lymph node metastasis and prognosis of esophageal carcinoma].
    Xu Q; Liu ZK; Cao YK; Li YM; Zhu SC
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):684-7. PubMed ID: 23159082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposed modifications of supraclavicular lymph node metastasis in the esophageal squamous cell carcinoma staging system for improved survival stratification.
    Zheng Y; Wang Z; Wang F; Huang Q; Liu S
    Oncotarget; 2017 Jun; 8(25):41563-41571. PubMed ID: 28147340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supraclavicular lymph node incisional biopsies have no influence on the prognosis of advanced non-small cell lung cancer patients: a retrospective study.
    Dong S; Zhao N; Deng W; Sun HW; Niu FY; Yang JJ; Zhong WZ; Li F; Yan HH; Xu CR; Zhang QY; Yang XN; Liao RQ; Nie Q; Wu YL
    World J Surg Oncol; 2017 Jan; 15(1):12. PubMed ID: 28069039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of salvage therapies for isolated para-aortic lymph node recurrence in patients with uterine cervical cancer after definitive treatment.
    Kubota H; Tsujino K; Sulaiman NS; Sekii S; Matsumoto Y; Ota Y; Soejima T; Yamaguchi S; Sasaki R
    Radiat Oncol; 2019 Dec; 14(1):236. PubMed ID: 31878944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definitive salvage radiation therapy and chemoradiation therapy for lymph node oligo-recurrence of esophageal cancer: a Japanese multi-institutional study of 237 patients.
    Yamashita H; Jingu K; Niibe Y; Katsui K; Matsumoto T; Nishina T; Terahara A
    Radiat Oncol; 2017 Feb; 12(1):38. PubMed ID: 28219406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical nodal metastases of unresectable thoracic esophageal squamous cell carcinoma: characteristics of long-term survivors after concurrent chemoradiotherapy.
    Liu H; Lu L; Zhu Q; Hao Y; Mo Y; Liu M; Hu Y; Cui N; Rong T
    Radiother Oncol; 2011 May; 99(2):181-6. PubMed ID: 21620504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognosis and Risk Stratification Based on Pelvic Lymph Node Characteristics in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Treated With Concurrent Chemoradiotherapy.
    Li X; Wei LC; Zhang Y; Zhao LN; Li WW; Ping LJ; Dang YZ; Hu J; Shi M
    Int J Gynecol Cancer; 2016 Oct; 26(8):1472-9. PubMed ID: 27400321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors, patterns of recurrence and toxicity for patients with esophageal cancer undergoing definitive radiotherapy or chemo-radiotherapy.
    Haefner MF; Lang K; Krug D; Koerber SA; Uhlmann L; Kieser M; Debus J; Sterzing F
    J Radiat Res; 2015 Jul; 56(4):742-9. PubMed ID: 25907360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Importance of Supraclavicular Lymph Node Metastasis After Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.
    Miyata H; Yamasaki M; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
    Ann Surg; 2015 Aug; 262(2):280-5. PubMed ID: 25211269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.